Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas.
Two independent growth factor-generated signals regulate c-fos and c-myc mRNA levels in Swiss 3T3 cells.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas.
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas. Sci Adv. 2021 03; 7(13).
View in:
PubMed
subject areas
Animals
Cancer Vaccines
Lymphangiogenesis
Lymphatic Metastasis
Melanoma
Mice
T-Lymphocytes
Vascular Endothelial Growth Factor C
authors with profiles
Jeffrey Hubbell
Melody Swartz